Australia Genomics Market Size & Outlook, 2023-2030

The genomics market in Australia is expected to reach a projected revenue of US$ 1,791.7 million by 2030. A compound annual growth rate of 18.3% is expected of Australia genomics market from 2024 to 2030.

Revenue, 2023 (US$M)
$552.2
Forecast, 2030 (US$M)
$1,791.7
CAGR, 2024 - 2030
18.3%
Report Coverage
Australia

Australia genomics market highlights

  • The Australia genomics market generated a revenue of USD 552.2 million in 2023 and is expected to reach USD 1,791.7 million by 2030.
  • The Australia market is expected to grow at a CAGR of 18.3% from 2024 to 2030.
  • In terms of segment, functional genomics was the largest revenue generating application in 2023.
  • Pathway Analysis is the most lucrative application segment registering the fastest growth during the forecast period.


Genomics market data book summary

Market revenue in 2023USD 552.2 million
Market revenue in 2030USD 1,791.7 million
Growth rate18.3% (CAGR from 2023 to 2030)
Largest segmentFunctional genomics
Fastest growing segmentPathway Analysis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationFunctional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery
Key market players worldwideAgilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A


Other key industry trends

  • In terms of revenue, Australia accounted for 1.7% of the global genomics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China genomics market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,434.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Genomics Market Scope

Genomics market segmentation & scope
Real-time PCR
Transfection
SNP analysis
Mutational analysis
Microarray analysis
RNA interference
Bisulfite sequencing
Microarray analysis
Chromatin immunoprecipitation (ChIP & ChIP-Seq)
Methylated DNA immunoprecipitation (MeDIP)
High resolution melt (HRM)
Chromatin accessibility assays
Microarray analysis
Bead-based analysis
Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
Real-time PCR
DNA sequencing
Microarray analysis
Real-time PCR
Mass spectrometry
Statistical analysis
Bioinformatics
Others
Instruments/Systems/Softwares
Consumables & Reagents
NGS-based Services
Core Genomics Services
Biomarker Translation Services
Computational Services
Others
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Academic and Government Institutes
Clinical Research
Other End Users

Genomics Market Companies

Name Profile # Employees HQ Website

Australia genomics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.


Functional genomics was the largest segment with a revenue share of 31.94% in 2023. Horizon Databook has segmented the Australia genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.


The national network of research, Australian Genomics, is engaged in creating building blocks for the smooth and complete integration of genomic medicine in routine healthcare. This network is a collaboration of 80 hospitals, laboratories that perform genetic testing, research institutes, and data management services.

Australian Genomics is adopting strategic initiatives to bridge the gap between the commercial implications of genomics and associated research activities. This robust research network is coupled with the advent of new genetic testing technologies, which is further driving the demand for cancer treatments, gene therapies, and personalized medicine developed based on individual genetic makeup.

In December 2021, the Australian Federal Police announced using massively parallel sequencing or NGS technology to predict traits of criminals from the DNA collected from crime scenes. This would allow investigators to predict biogeographical ancestry, gender, eye color, and hair color. The potential application of NGS in forensic research is expected to further boost the demand for NGS in the market.

Reasons to subscribe to Australia genomics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia genomics market databook

  • Our clientele includes a mix of genomics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia genomics market , including forecasts for subscribers. This country databook contains high-level insights into Australia genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia genomics market size, by application, 2018-2030 (US$M)

Australia Genomics Market Outlook Share, 2023 & 2030 (US$M)

Australia genomics market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more